CDEK
← All organizations

Instituto Bioclon

For profitContributed to NME

Also known as: Bioclon | Instituto Bioclon S.A. de C.V.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Apr 1, 2004

First marketed drug

May 6, 2015

First NDA

May 6, 2015

Last known activity

Jun 1, 2017

Timeline

1990s

  1. Jan 1, 1990

    Instituto Bioclon— Founded

2010s

  1. May 6, 2015

    crotalidae immune f(ab')2 (equine)— NDA Organization

Drugs by trial phase (7 distinct, 10 trials)

Phase 4 (1 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (21)

Details

Founded
Mexico City, MX Jan 1, 1990
First NDA
May 6, 2015
Last known activity
Jun 1, 2017

Designations held

  • Orphan drug